Rapid Analysis of Infections by Spectrometry of Exhaled Breath
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorUniversitaire Ziekenhuizen KU Leuven
About this trial
To quantify the diagnostic, prognostic and therapeutic value of spectrometric analysis of exhaled breath from hematological patients with respiratory infection.
Eligibility criteria
Qualifiers
Age ≥ 18y at start of study
De novo, refractory or relapsed AML/MDS receiving intensive chemotherapy
De novo, refractory or relapsed ALL/T-lymphoblastic lymphoma receiving intensive chemotherapy
Aplastic anemia requiring ATG therapy
Disqualifiers
Hematological disease beyond the specified inclusion criteria
Signs of active respiratory infection
If previously enrolled: incomplete clearance of all signs of respiratory infection (both clinically, microbiologically and radiologically).
Trial design
Treatments tested in this trial
- Breath analysis
Treatment groups
No treatment groups listed
Sponsors and collaborators
Source ClinicalTrials.gov